We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Antibiotics May Not Be Needed Following Abscess Incision and Drainage

By HospiMedica International staff writers
Posted on 19 Apr 2010
Antibiotics do not improve outcomes after incision and drainage of uncomplicated skin abscesses, but may perhaps prevent new abscesses at one month, according to a new study.

Researchers at Washington Hospital Center (DC, USA) and Wilford Hall Medical Center (Lackland Air Force Base, TX, USAl) conducted a multicenter trial that randomized 212 adults to receive either trimethoprim-sulfamethoxazole (TS, 160 mg/800 mg) or placebo after incision and drainage of community-acquired abscesses. More...
The researchers assessed treatment failure using clinical follow-up, telephone follow-up, and medical record review, recording the development of new lesions within 30 days. All bacterial isolates tested were uniformly sensitive to TS; thus, the primary outcome was treatment failure at 7 days (defined as no improvement after 2 days), development of a new separate abscess within 7 days, or worsening infection within 7 days requiring intervention. In all, 88 patients in the antibiotic group and 102 in the placebo group completed 7 days of follow-up; of these, 46 and 50, respectively, returned at 30 days.

The researchers found that there was no significant difference in treatment failure rates at 7 days (17% in the antibiotic group and 26% in the placebo group). A statistically similar incidence of treatment failure was observed in patients receiving TS compared to placebo. On 30-day follow-up (successful in 69% of the patients), the researchers observed significantly fewer new lesions in the antibiotic (9%) versus the placebo (28%) group. The study was published early online on March 29, 2010, in the Annals of Emergency Medicine.

"Antibiotics don't help with resolution of infection,” said lead author Gillian R. Schmitz., M.D. "The most important thing is to open the wound, clean it, and get the pus out; more study needs to be done to draw a conclusion about recurrence, because we lost so many to follow-up at 30 days.”

Pus consists of a thin, protein-rich fluid, known as liquor puris, and dead cells, which are part of the body's immune response. When neutrophils are needed to fight infection, they move to the site of infection by a process known as chemotaxis, usually triggered by cytokines released from macrophages that sense invading organisms. At the site of infection, the neutrophils engulf and kill bacteria. Eventually, the neutrophils die, and are then phagocytosed by macrophages, which break them down further. Pus is the viscous material composed of these dead neutrophils.

Related Links:
Washington Hospital Center
Wilford Hall Medical Center


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.